Page last updated: 2024-08-25

chitosan and dinaciclib

chitosan has been researched along with dinaciclib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ahmadi, A; Assali, A; Atyabi, F; Ghalamfarsa, G; Ghani, S; Hajizadeh, F; Izadi, S; Jadidi-Niaragh, F; Karoon Kiani, F; Karpisheh, V; Kheiry, H; Masjedi, A; Mirzazadeh Tekie, FS; Moslehi, A; Namdar, A; Rafiee, B; Sojoodi, M	1

Other Studies

1 other study(ies) available for chitosan and dinaciclib

Article	Year
Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression. Pharmaceutical research, 2020, Sep-17, Volume: 37, Issue:10 Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Chitosan; Cyclic N-Oxides; Graphite; Hyaluronic Acid; Hypoxia-Inducible Factor 1, alpha Subunit; Indolizines; Mice; Nanoparticles; Neoplasms, Experimental; Pyridinium Compounds; RNA, Small Interfering	2020

Article

Year

Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression.

Pharmaceutical research, 2020, Sep-17, Volume: 37, Issue:10

Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Chitosan; Cyclic N-Oxides; Graphite; Hyaluronic Acid; Hypoxia-Inducible Factor 1, alpha Subunit; Indolizines; Mice; Nanoparticles; Neoplasms, Experimental; Pyridinium Compounds; RNA, Small Interfering

2020